Evidence map›Paper›PMID 24958637›Full record

ArticleAnnals of epidemiology2014

Systemic glucocorticoid use and early-onset basal cell carcinoma.

Jose Ramon Troche, Leah M Ferrucci, Brenda Cartmel, David J Leffell, Allen E Bale, Susan T Mayne

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jose Ramon TrocheDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.
Leah M FerrucciDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT.
Brenda CartmelDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT.
David J LeffellYale Cancer Center, New Haven, CT; Departments of Dermatology and Surgery, Yale University School of Medicine, New Haven, CT.
Allen E BaleYale Cancer Center, New Haven, CT; Department of Genetics, Yale University School of Medicine, New Haven, CT.
Susan T MayneDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT; Yale Cancer Center, New Haven, CT. Electronic address: susan.mayne@yale.edu.

Funding

Yale SPORE in Skin CancerP50CA121974 · NCI · YALE UNIVERSITY · PI DAVID F STERN · 2006 to 2026
$43.9M
Yale/NCI Cooperative Training Program in Cancer EpidemiologyT32CA105666 · NCI · YALE UNIVERSITY · PI MA, XIAOMEI · 2008 to 2012
$603k
Epidemiology, genetics, and behaviors in a study of basal cell carcinomaF32CA144335 · NCI · YALE UNIVERSITY · PI FERRUCCI, LEAH MCARTHUR · 2010 to 2012
$115k
NCI NIH HHS F32 CA144335NCI NIH HHS P50 CA121974NCI NIH HHS T32 CA105666
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultBasal Cell CarcinomaCase-Control StudiesComorbidityConnecticutFemaleGlucocorticoidsHumansHypersensitivityImmunosuppressive AgentsInflammationMaleRisk FactorsSkin NeoplasmsGlucocorticoidsImmunosuppressive AgentsBasal cell carcinomaCase-controlEpidemiologyGlucocorticoidsImmunosuppressivesKeratinocyte carcinomaNonmelanoma skin cancer

Identifiers

PMID24958637
PMCPMC4119504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.